ST. CLOUD, Minn. -- Imagine one of the worst pains you've ever felt in your life. Now imagine someone telling you it's all in your head. "It was extremely frustrating," said Karen Linnell, who was ...

Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For nearly three-quarters of obese patients with fibromyalgia, ...

Scientists still may not know the exact cause of fibromyalgia, but that hasn’t stopped them from developing treatments for the chronic pain associated with the condition. For years, all of those ...

Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. Fifteen years later, the New Jersey company has accomplished its mission with the FDA's endorsement of ...

Please provide your email address to receive an email when new articles are posted on . The approval is supported by data from multiple phase 3 clinical trials evaluating Tonmya’s safety and efficacy.

TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...